Sale!

SPTBN2 Gene Spinocerebellar Ataxia Type 5 Autosomal Dominant Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SPTBN2 Gene Spinocerebellar Ataxia Type 5 Autosomal Dominant NGS Genetic DNA Test is a specialized diagnostic tool that identifies mutations in the SPTBN2 gene responsible for spinocerebellar ataxia type 5 (SCA5). This comprehensive genetic analysis utilizes next-generation sequencing technology to detect autosomal dominant inheritance patterns of this progressive neurological disorder. The test provides crucial information for individuals experiencing coordination difficulties, balance problems, or with family history of cerebellar ataxia. Early detection enables proactive management strategies and informed family planning decisions. Results are typically available within 3-4 weeks from blood or DNA samples. This essential neurological genetic test is available for $500 USD, offering significant savings from the regular $700 price.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SPTBN2 Gene Spinocerebellar Ataxia Type 5 Autosomal Dominant NGS Genetic DNA Test

Comprehensive Introduction to SPTBN2 Genetic Testing

The SPTBN2 Gene Spinocerebellar Ataxia Type 5 Autosomal Dominant NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced testing methodology provides critical insights into hereditary cerebellar ataxia disorders, specifically targeting mutations in the SPTBN2 gene that cause spinocerebellar ataxia type 5. As an autosomal dominant condition, SCA5 follows a clear inheritance pattern where affected individuals have a 50% chance of passing the mutation to their offspring. Early detection through this comprehensive genetic analysis enables proactive medical management and informed family planning decisions.

What This Advanced Genetic Test Measures

Our specialized NGS genetic DNA test meticulously examines the SPTBN2 gene for pathogenic variants associated with spinocerebellar ataxia type 5. The test specifically detects:

  • Point mutations and small insertions/deletions in the SPTBN2 gene
  • Autosomal dominant inheritance patterns characteristic of SCA5
  • Genetic markers indicating progressive cerebellar degeneration
  • Specific variants affecting beta-III spectrin protein function
  • Mutation types including missense, nonsense, and frameshift variations

Who Should Consider SPTBN2 Genetic Testing

This comprehensive genetic test is particularly recommended for individuals experiencing:

  • Progressive coordination difficulties and balance problems
  • Family history of cerebellar ataxia or unexplained neurological disorders
  • Early-onset gait abnormalities and limb coordination issues
  • Speech difficulties or dysarthria developing in adulthood
  • Eye movement abnormalities including nystagmus
  • Individuals planning pregnancy with known family history of SCA5

Significant Benefits of SPTBN2 Genetic Testing

Undergoing SPTBN2 genetic testing provides numerous advantages for patients and families:

  • Early and accurate diagnosis of spinocerebellar ataxia type 5
  • Clear understanding of inheritance patterns for family planning
  • Opportunity for proactive symptom management and treatment planning
  • Reduction of diagnostic uncertainty and unnecessary medical procedures
  • Access to specialized neurological care and support resources
  • Psychological relief from diagnostic ambiguity
  • Foundation for personalized therapeutic approaches

Understanding Your Genetic Test Results

Our comprehensive genetic counseling support helps you interpret your SPTBN2 test results effectively:

  • Positive Result: Indicates presence of SPTBN2 mutation; enables proactive management and family screening
  • Negative Result: No detected mutation; significantly reduces SCA5 risk but doesn’t eliminate other neurological conditions
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • All results include detailed genetic counseling to ensure complete understanding
  • Follow-up testing recommendations based on individual findings

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across the United States, with specialized neurology genetics departments in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other locations. Our network ensures convenient access to advanced genetic testing services regardless of your location.

Take Control of Your Neurological Health Today

Don’t let uncertainty about hereditary neurological conditions affect your quality of life. Our SPTBN2 Gene Spinocerebellar Ataxia Type 5 Autosomal Dominant NGS Genetic DNA Test provides the clarity and confidence you need for informed health decisions. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood drops, accessing this crucial genetic information has never been more convenient.

Schedule your genetic counseling session and test appointment today by calling our dedicated genetics specialists at +1(267) 388-9828 or book online through our secure patient portal. Take the first step toward understanding your neurological health and securing your family’s genetic future.